Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta with Platinum and Erbitux in Head and Neck Cancer
NCT01087970Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2010
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pemetrexed in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Eli Lilly and Company. Started Aug 2010; status: completed.
02
Drugs
pemetrexed
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01087970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087970.